Acuta Capital Partners as of June 30, 2020
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 46 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adverum Biotechnologies | 10.5 | $37M | 1.7M | 20.88 | |
| Immunomedics | 5.6 | $19M | 545k | 35.44 | |
| Bioxcel Therapeutics (BTAI) | 5.2 | $18M | 341k | 53.01 | |
| Iovance Biotherapeutics (IOVA) | 4.7 | $16M | 590k | 27.45 | |
| Mersana Therapeutics (MRSN) | 4.3 | $15M | 633k | 23.40 | |
| Kura Oncology (KURA) | 4.1 | $14M | 873k | 16.30 | |
| Avadel Pharmaceuticals Sponsored Adr | 4.1 | $14M | 1.8M | 8.08 | |
| Celldex Therapeutics Com New (CLDX) | 3.8 | $13M | 1.0M | 13.00 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 3.4 | $12M | 1.2M | 10.01 | |
| Relmada Therapeutics (RLMD) | 3.0 | $11M | 235k | 44.75 | |
| Larimar Therapeutics (LRMR) | 3.0 | $10M | 823k | 12.48 | |
| BioCryst Pharmaceuticals (BCRX) | 2.6 | $9.1M | 1.9M | 4.77 | |
| Catalyst Biosciences Com New | 2.5 | $8.8M | 1.5M | 5.87 | |
| Karuna Therapeutics Ord | 2.5 | $8.7M | 78k | 111.46 | |
| Immunovant (IMVT) | 2.5 | $8.5M | 350k | 24.35 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 2.4 | $8.2M | 56k | 147.89 | |
| Bellus Health Com New | 2.3 | $7.9M | 765k | 10.29 | |
| Axsome Therapeutics (AXSM) | 2.1 | $7.4M | 90k | 82.28 | |
| Merus N V (MRUS) | 2.1 | $7.4M | 460k | 16.09 | |
| Selecta Biosciences | 1.9 | $6.7M | 2.4M | 2.84 | |
| Applied Therapeutics (APLT) | 1.9 | $6.6M | 182k | 36.15 | |
| Kadmon Hldgs | 1.9 | $6.6M | 1.3M | 5.12 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $6.5M | 518k | 12.54 | |
| Apellis Pharmaceuticals (APLS) | 1.8 | $6.2M | 190k | 32.66 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 1.8 | $6.2M | 560k | 11.00 | |
| Altimmune Com New (ALT) | 1.7 | $5.8M | 538k | 10.71 | |
| Vir Biotechnology (VIR) | 1.5 | $5.2M | 127k | 40.97 | |
| Verastem | 1.3 | $4.6M | 2.7M | 1.72 | |
| Dicerna Pharmaceuticals | 1.2 | $4.3M | 170k | 25.40 | |
| Arvinas Ord (ARVN) | 1.2 | $4.1M | 123k | 33.54 | |
| Aldeyra Therapeutics (ALDX) | 1.1 | $3.7M | 890k | 4.17 | |
| Agenus Com New | 1.1 | $3.7M | 933k | 3.93 | |
| Syndax Pharmaceuticals (SNDX) | 1.0 | $3.6M | 241k | 14.82 | |
| Iveric Bio | 1.0 | $3.5M | 688k | 5.10 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $3.3M | 118k | 28.26 | |
| Eiger Biopharmaceuticals | 0.8 | $2.8M | 293k | 9.60 | |
| Uniqure Nv SHS (QURE) | 0.8 | $2.7M | 60k | 45.07 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.7 | $2.6M | 60k | 43.18 | |
| Reata Pharmaceuticals Cl A | 0.7 | $2.4M | 15k | 156.01 | |
| Fusion Pharmaceuticals | 0.7 | $2.4M | 135k | 17.47 | |
| Generation Bio (GBIO) | 0.6 | $2.1M | 100k | 21.00 | |
| Cardiff Oncology (CRDF) | 0.6 | $2.0M | 408k | 5.01 | |
| Surface Oncology | 0.4 | $1.5M | 225k | 6.56 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $1.1M | 108k | 10.41 | |
| Satsuma Pharmaceuticals Ord | 0.3 | $1.0M | 35k | 28.77 | |
| Akouos | 0.1 | $500k | 22k | 22.52 |
